The extent of tumor-infiltrating lymphocytes (TILs), along with immunomodulatory ligands, tumor-mutational burden and other biomarkers, has been demonstrated to be a marker of response to immune-checkpoint therapy in several cancers. Pathologists have therefore started to devise standardized visual approaches to quantify TILs for therapy prediction. However, despite successful standardization efforts visual TIL estimation is slow, with limited precision and lacks the ability to evaluate more complex properties such as TIL distribution patterns. Therefore, computational image analysis approaches are needed to provide standardized and efficient TIL quantification. Here, we discuss different automated TIL scoring approaches ranging from classi...
Auteurs : International Immuno-Oncology Biomarker Working GroupInternational audienceAssessment of t...
Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part o...
Abstract: The clinical significance of the tumor-immune interaction in breast cancer is now establis...
The extent of tumor-infiltrating lymphocytes (TILs), along with immunomodulatory ligands, tumor-muta...
The extent of tumor-infiltrating lymphocytes (TILs), along with immunomodulatory ligands, tumor-muta...
Increased levels of tumor-infiltrating lymphocytes (TILs) indicate favorable outcomes in many types ...
Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part o...
Auteurs : International Immuno-Oncology Biomarker Working GroupInternational audienceAssessment of t...
Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part o...
Abstract: The clinical significance of the tumor-immune interaction in breast cancer is now establis...
The extent of tumor-infiltrating lymphocytes (TILs), along with immunomodulatory ligands, tumor-muta...
The extent of tumor-infiltrating lymphocytes (TILs), along with immunomodulatory ligands, tumor-muta...
Increased levels of tumor-infiltrating lymphocytes (TILs) indicate favorable outcomes in many types ...
Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part o...
Auteurs : International Immuno-Oncology Biomarker Working GroupInternational audienceAssessment of t...
Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part o...
Abstract: The clinical significance of the tumor-immune interaction in breast cancer is now establis...